Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q3 2022 Program Management Update

31 Oct 2022 07:00

RNS Number : 5708E
R&Q Insurance Holdings Ltd
31 October 2022
 

 

R&Q Insurance Holdings Ltd

 

Q3 2022 Program Management Update

 

GWP grows by over 80% to $1.3 billion for the nine months ending 30 September 2022

 

31 October 2022

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business for the nine months ending 30 September 2022.

 

Highlights

 

· Gross Written Premium ('GWP') of $1.3 billion (9m 2021: $714 million), an 83% increase

 

· Program Fee Income of $60 million (9m 2021: $30 million), a 100% increase1

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business exhibited strong year-over-year growth as we continued to expand the depth and breadth of our MGA partnerships through the first nine months of 2022. Our team continues to find new and unique ways to meet the needs of our MGAs and reinsurance partners, as demonstrated in our recently announced multi-year transaction with Inperio. Additionally, I am pleased to report that our growth is broad-based with all three of our platforms (US Admitted, US Non-Admitted, and Europe) growing GWP and Fee Income. Looking forward, our pipeline of new MGA opportunities remains strong."

 

Notes:

1. Program Fee Income is on a written basis and excludes our share of earnings from minority stakes in MGAs.

 

Ends

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon

Tel: 0207 780 5850

Alan Quilter Tel: 020 7780 5960

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

Anusuya Nayar Gupta

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKKBNDBDDFKN
Date   Source Headline
22nd Jun 201112:38 pmRNSResult of AGM
22nd Jun 20117:00 amRNSAGM Statement
13th Jun 20113:52 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
27th May 20114:16 pmRNSNotice of AGM
25th May 20115:12 pmRNSCREST Entitlement Credited
16th May 20113:31 pmRNSCREST Entitlement Credited
13th May 20117:00 amRNSSuccessful Outcome of Legal Dispute
12th May 201112:48 pmRNSNotification of Major Interest in Shares
28th Apr 20117:00 amRNSFinal Results
27th Apr 20114:38 pmRNSResult of Meeting
8th Apr 201111:04 amRNSNotification of Major Interest in Shares
5th Apr 201111:17 amRNSNotice of Results
7th Mar 20115:37 pmRNSNotification of Major Interest in Shares
1st Mar 20113:09 pmRNSExercise of Options
24th Feb 20112:05 pmRNSNotification of Major Interest In Shares
16th Feb 20113:18 pmRNSNotification of Major Interest in Shares
16th Feb 20111:29 pmRNSNotification of Major Interest In Shares
15th Feb 201112:30 pmRNSNotification of Major Interest in Shares
14th Feb 20115:38 pmRNSNotification of Major Interest In Shares
12th Jan 201112:55 pmRNSDirector Appointment
7th Dec 201012:27 pmRNSIssue of Equity
10th Nov 20107:00 amRNSApproval of two Managing General Agents (MGAs)
8th Nov 20107:00 amRNSApproval of new syndicate on turnkey basis
1st Nov 20107:00 amRNSCompletion of acquisition
24th Sep 20105:25 pmRNSHolding(s) in Company
16th Sep 20104:53 pmRNSHolding(s) in Company
15th Sep 201011:04 amRNSDirector/PDMR Shareholding
13th Sep 20107:00 amRNSAcquisition of RSL businesses and ETMC.
6th Sep 20101:20 pmRNSHolding(s) in Company
3rd Sep 201012:06 pmRNSResult of General Meeting
20th Aug 20104:20 pmRNSDirector/PDMR Shareholding
19th Aug 20102:20 pmRNSDirector/PDMR Shareholding
18th Aug 20107:00 amRNSReturn of Cash and Share Capital Consolidation
18th Aug 20107:00 amRNSHalf Yearly Report
9th Aug 20107:00 amRNSTrading Statement
30th Jul 20104:53 pmRNSNotification of Major Interest in Shares
30th Jul 20108:51 amRNSNotification of Major Interest in Shares
1st Jul 20109:17 amRNSNotice of Results
23rd Jun 201012:18 pmRNSAGM Statement
16th Jun 20109:43 amRNSNotice of AGM
8th Jun 20101:31 pmRNSChanges to the register of director information
29th Apr 20107:00 amRNSFinal Results
28th Apr 20101:12 pmRNSAppointment of Nominated Advisor and Joint Broker
23rd Apr 20107:00 amRNSAcquisition
22nd Mar 20107:00 amRNSTrading Update
25th Feb 201012:16 pmRNSInterim Dividend
18th Feb 20107:00 amRNSChange of Adviser Name
10th Feb 20107:14 amRNSNotice of Results
10th Feb 20107:10 amRNSChange of Adviser
29th Jan 20107:00 amRNSAgreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.